Danny Burke, CEO of ecancer, shared a post on LinkedIn:
“Hear the latest advances in multigene testing in early breast cancer from leading experts Prof Nadia Harbeck and Prof Giuseppe Curigliano.
This expert interview, which explores how evolving genomic tools are shaping treatment decision-making in early-stage disease, is part of our series of expert interviews from the recent San Antonio Breast Cancer Symposium. Watch the full video.”
More posts featuring Danny Burke.